COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Q3 2020 Earnings Conference Call November 06, 2020 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler Lachlan Hanbury-Brown - William Blair Greg Fraser - Truist Securities Serge Belanger - Needham & Company David Steinberg - Jefferies Brandon Folkes - Cantor Fitzgerald Kevin Kedra - G Research Presentation Operator Greetings, and welcome to the Collegium Pharmaceutical, Inc. Third Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the former presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Alex Dasalla, Head of Investor Relations for Collegium. Alex Dasalla Thank you. Please go ahead. Welcome to

For further details see:

Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call Transcript